Evidence map›Paper›PMID 27730209›Full record

ArticleScience advances2016

Combinatorial microfluidic droplet engineering for biomimetic material synthesis.

Lukmaan A Bawazer, Ciara S McNally, Christopher J Empson, William J Marchant, Tim P Comyn, Xize Niu, Soongwon Cho, Michael J McPherson, Bernard P Binks, Andrew deMello and 1 more

Abstract read
In one paragraph

Article in Science advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Light-Fueled Submarine-Like Droplet.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lukmaan A BawazerSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, U.K.
Ciara S McNallySchool of Chemistry, University of Leeds, Leeds, LS2 9JT, U.K.
Christopher J EmpsonSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, U.K.ORCID 0000-0002-4808-8561
William J MarchantSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, U.K.
Tim P ComynInstitute for Materials Research, School of Process, Environmental and Materials Engineering, University of Leeds, Leeds LS2 9JT, U.K.
Xize NiuEngineering and the Environment, University of Southampton, Southampton SO17 1BJ, U.K.
Soongwon ChoSamsung Display, 465, Beonyeong-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do, Republic of Korea.
Michael J McPhersonSchool of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, U.K.ORCID 0000-0002-0719-6427
Bernard P BinksSurfactant & Colloid Group, Department of Chemistry, University of Hull, Hull HU6 7RX, U.K.
Andrew deMelloDepartment of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
Fiona C MeldrumSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, U.K.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although droplet-based systems are used in a wide range of technologies, opportunities for systematically customizing their interface chemistries remain relatively unexplored. This article describes a new microfluidic strategy for rapidly tailoring emulsion droplet compositions and properties. The approach uses a simple platform for screening arrays of droplet-based microfluidic devices and couples this with combinatorial selection of the droplet compositions. Through the application of genetic algorithms over multiple screening rounds, droplets with target properties can be rapidly generated. The potential of this method is demonstrated by creating droplets with enhanced stability, where this is achieved by selecting carrier fluid chemistries that promote titanium dioxide formation at the droplet interfaces. The interface is a mixture of amorphous and crystalline phases, and the resulting composite droplets are biocompatible, supporting in vitro protein expression in their interiors. This general strategy will find widespread application in advancing emulsion properties for use in chemistry, biology, materials, and medicine.

Indexed as

Lab-On-A-Chip DevicesBiomimetic MaterialsMicrofluidic Analytical TechniquesTitaniumTitaniumtitanium dioxideartificial cellbio-inspiredBiomineralizationcombinatorialemulsiongenetic algorithmmicrofluidics

Identifiers

PMID27730209
PMCPMC5055387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.